Link between endometriosis and ovarian-cancer subtypes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Immune pathway through endometriosis to ovarian cancer.World journal of clinical oncology · 2024
   Review
2. ARID1a Gene as a Potential Early Marker to Tackle Endometriosis-Associated Ovarian Cancer.Aging and disease · 2023
   Review
3. RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer.Frontiers in oncology · 2022
   Article
4. Does the Presence of Endometriosis Affect Prognosis of Ovarian Cancer?Cancer investigation · 2016
   Article
5. Strong Association Between Endometriosis and Symptomatic Leiomyomas.JSLS : Journal of the Society of Laparoendoscopic Surgeons
   Article

Corrections and comments

• Comment on
  Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.2012

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as